Examiner Rama P. Ramanujam
Grant ratio: 74.0% (83rd percentile in Art Unit 1652 among examiners with at least 20 applications). Average office actions per grant: 1.32. Most common rejection type: §103.
Appears inactive
Last office action in data: April 2014
Examiner record
Save this analysis
Download this examiner report.
Log in / Sign Up to exportPeer comparisons
| Group | Examiners | Average grant ratio | Average office actions / grant |
|---|---|---|---|
| Art Unit | 24 | 43.9% | 1.73 |
| Group | 209 | 40.0% | 2.00 |
| Tech Center | 1,380 | 37.5% | 2.02 |
| USPTO | 16,572 | 52.1% | 1.98 |
Office actions per application
| Office actions | Applications | Share of applications |
|---|---|---|
| No OA observed | 0 | 0.0% |
| 1 OA | 34 | 68.0% |
| 2 OAs | 12 | 24.0% |
| 3 OAs | 2 | 4.0% |
| 4 OAs | 1 | 2.0% |
| 5+ OAs | 1 | 2.0% |
Each application is counted once. “5+” includes all higher counts.
Grant history
Recent ratios may be lower while applications remain pending.
Yearly counts
| Year | Applications | Grants | Grant rate |
|---|---|---|---|
| 2012 | 3 | 1 | 33.3% |
| 2013 | 41 | 30 | 73.2% |
| 2014 | 6 | 6 | 100.0% |
Rejections by office-action stage
| Office-action stage | Actions observed | §101 | §102 | §103 | §112 |
|---|---|---|---|---|---|
| Action 1 | 50 | 2.0% | 4.0% | 58.0% | 32.0% |
| Action 2 | 16 | 6.3% | 0.0% | 50.0% | 43.8% |
| Action 3 | 4 | 0.0% | 0.0% | 75.0% | 25.0% |
| Action 4 | 2 | 0.0% | 0.0% | 100.0% | 0.0% |
| Action 5 | 1 | 0.0% | 0.0% | 100.0% | 0.0% |
| Action 6 | 1 | 0.0% | 0.0% | 100.0% | 0.0% |
| Action 7 | 1 | 0.0% | 0.0% | 100.0% | 0.0% |
| Action 8 | 1 | 0.0% | 0.0% | 100.0% | 0.0% |
Section 101 rejections
Last 3 years: 2023-10-02–2026-10-02. All years includes every dated office action in the data.
By year
0.0%
0.0%
0.0%
0.0%
0.0%
3.7%
2014: Alice
0.0%
Each bar is the percentage of office actions with a §101 rejection.
PTAB appeals
No PTAB decisions could be matched to this examiner.
Older and transferred applications may not have a reliable examiner match. Data through Oct. 9, 2026.